Fabino Life Sciences
Fabino Life Sciences Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Fabino Life Sciences
Start SIPFabino Life Sciences Investment Rating
-
Master Rating:
-
Fabino Life Sciences has an operating revenue of Rs. 17.54 Cr. on a trailing 12-month basis. An annual revenue growth of 38% is outstanding, Pre-tax margin of 2% needs improvement, ROE of 1% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. It is currently FORMING a base in its weekly chart and is trading around 17% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 152 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2022 |
|---|---|
| Total Revenue Annual Cr | 4 |
| Operating Expenses Annual Cr | 4 |
| Operating Profit Annual in Cr | 0 |
| Depreciation Cr | 0 |
| Interest Annual Cr | 0 |
| Tax Annual Cr | 0 |
| Net Profit Annual Cr | 0 |
Fabino Life Sciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 1
- Bearish Moving Average
- ___
- 12
- 20 Day
- 31.09
- 50 Day
- 31.03
- 100 Day
- 31.16
- 200 Day
- 20 Day
- 31.56
- 50 Day
- 31.32
- 100 Day
- 29.52
- 200 Day
Fabino Life Sciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 31.4 |
| Second Resistance | 31.4 |
| Third Resistance | 31.4 |
| RSI | 46.94 |
| MFI | 46 |
| MACD Single Line | -0.14 |
| MACD | -0.2 |
| Support | |
|---|---|
| First Resistance | 31.4 |
| Second Resistance | 31.4 |
| Third Resistance | 31.4 |
Fabino Life Sciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 3,000 | 300,000 | 100 |
| Week | 3,000 | 300,000 | 100 |
| 1 Month | |||
| 6 Month | 2,202 | 183,879 | 83.52 |
Fabino Life Sciences Result Highlights
Fabino Life Sciences Synopsis
BSE-Medical-Biomed/Biotech
Fabino Life Sciences belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 4.20 Cr. and Equity Capital is Rs. 2.10 Cr. for the Year ended 31/03/2022. Fabino Life Sciences Ltd. is a Public Limited Listed company incorporated on 27/10/2011 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is U24100DL2011PLC226781 and registration number is 226781.| Market Cap | 0 |
| Sales | 4 |
| Shares in Float | 0.09 |
| No of funds | |
| Yield |
| Book Value | 1.61 |
| U/D Vol ratio | 1.3 |
| LTDebt / Equity | 1 |
| Alpha | 0.36 |
| Beta | -0.4 |
Fabino Life Sciences
| Owner Name | Sep-22 | Mar-22 |
|---|---|---|
| Promoters | 56.82% | 56.82% |
| Individual Investors | 28.32% | 32.04% |
| Others | 14.86% | 11.14% |
Fabino Life Sciences Management
| Name | Designation |
|---|---|
| Mr. Atul Kumar Jain | Executive & Managing Director |
| Mr. Aditya Mahavir Jain | Non Executive Director |
| Mr. Arihant Jain | Non Executive Director |
| Mr. Kuldeep Singh Solanki | Independent Director |
| Mr. Tesu Alakh | Independent Director |
| Mr. Gagan Gupta | Independent Director |
| Mr. Sumit Malik | Non Exe.Additional Director |
Fabino Life Sciences Forecast
Price Estimates
Fabino Life Sciences FAQs
What is Share Price of Fabino Life Sciences ?
Fabino Life Sciences share price is ₹30 As on 31 March, 2023 | 18:01
What is the Market Cap of Fabino Life Sciences ?
The Market Cap of Fabino Life Sciences is ₹6.3 Cr As on 31 March, 2023 | 18:01
What is the P/E ratio of Fabino Life Sciences ?
The P/E ratio of Fabino Life Sciences is As on 31 March, 2023 | 18:01
What is the PB ratio of Fabino Life Sciences ?
The PB ratio of Fabino Life Sciences is 1.5 As on 31 March, 2023 | 18:01